Lifeward Ltd. Announces Public Offering Details
Today, Lifeward Ltd. (NASDAQ: LFWD) reported significant news regarding its plans to raise capital through a public offering. The company, known for its pioneering medical technology aimed at improving the quality of life for individuals with physical challenges, plans to offer approximately 4 million shares alongside warrants to purchase an equal number of shares. Each unit is priced at $0.65, an approachable investment for those looking to participate in innovations in healthcare.
Understanding the Offering
Structure of the Offering
The offering includes ordinary shares and the associated warrants that will allow investors to purchase shares at the same price of $0.65. These warrants are immediately exercisable and have a five-year expiration period, providing investors with a strong opportunity to secure a position in the company as it continues to grow and innovate.
Usage of Proceeds
Lifeward anticipates that the public offering will generate approximately $2.6 million in gross proceeds, which will be allocated toward ongoing commercial initiatives and general corporate purposes. This capital is crucial for Lifeward as it continues to develop solutions that cater to individuals facing physical limitations, enhancing both their functionality and health in diverse environments.
Strategic Partnership
The company has engaged H.C. Wainwright & Co. as the exclusive placement agent for this offering. This collaboration is expected to streamline the process and connect Lifeward with interested investors effectively.
About Lifeward Ltd.
Lifeward is at the forefront of designing and delivering innovative solutions for physical rehabilitation and recovery. Their product line includes acclaimed technologies such as the ReWalk Exoskeleton and the AlterG Anti-Gravity System. Established in 2001, Lifeward operates globally, with a focus on enhancing the lives of those with disabilities.
Innovative Product Portfolio
The company’s products are not just advanced; they are transformative, supporting individuals in achieving greater independence. Lifeward's mission revolves around driving relentless innovation to enable individuals to do what they love without the limitations imposed by physical challenges.
Long-term Vision
This offering is not just a funding mechanism; it reflects Lifeward's long-term vision of expanding access to its life-changing technologies. By focusing on the needs of individuals with physical disabilities, the company aims to lead the market in rehabilitation technologies, providing options that improve clinical outcomes while promoting everyday functionality.
Frequently Asked Questions
What is the size of Lifeward's public offering?
Lifeward is offering approximately 4 million ordinary shares along with warrants to purchase an equal number of shares, targeting around $2.6 million in gross proceeds.
Who is the placement agent for the offering?
H.C. Wainwright & Co. has been appointed as the exclusive placement agent for Lifeward's public offering.
How will Lifeward use the proceeds from the offering?
The proceeds will be utilized for Lifeward's commercial efforts, working capital, and general corporate purposes to continue its mission of enhancing the lives of individuals with physical limitations.
What types of products does Lifeward offer?
Lifeward's product offerings include innovative solutions such as the ReWalk Exoskeleton and the AlterG Anti-Gravity System, aimed at supporting rehabilitation and recovery.
Which stock exchange is Lifeward listed on?
Lifeward Ltd. is listed on the NASDAQ under the ticker symbol LFWD.
